Latest Breaking News On - Lab at sydney garvan institute - Page 1 : comparemela.com

A landmark study has shown Ozempic can reduce the risk of death in people with serious heart problems who are overweight or obese but do not have diabetes.

New south walesGary wittertGarry jenningsStefanie zingsheimJohn davisJason kovacicKatherine samarasJohann hariFreemasons foundation centre for men health researchLab at sydney garvan instituteVictor chang cardiac research instituteHeart foundationNew england journalVictor chang cardiac researchClinical obesityAdipose biology